Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
49 Leser
Artikel bewerten:
(0)

Ophthalmology PACS Market Size Worth $170.96 Million by 2025: Grand View Research, Inc.

SAN FRANCISCO, January 15, 2019 /PRNewswire/ --

The global ophthalmology PACS market size is expected to reach USD 170.96 million by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 6.5% during the forecast period and is driven by rising adoption of Electronic Health Record (EHR) and Electronic Medical Records (EMR) solutions globally. Moreover, rising prevalence of eye diseases, such as cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy, is expected to fuel demand for ophthalmology PACS in near future. The Department of Ophthalmology of National University of Singapore conducted a study in collaboration with National University Health System, Singapore and South Central Asia. According to this study, the number of glaucoma cases diagnosed in 2013 was 17.06 million, which is anticipated to reach around 32.9 million by 2040.

(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Product development, geographical expansion and M&A are some sustainability strategies adopted by major companies in this market. For instance, in August 2017, Carl Zeiss Meditec Inc., acquired Veracity Innovations, LLC, a U.S.-based medical software company that delivers cloud-based platforms to maximize clinical performance and work efficiency. These platforms help ophthalmologists in delivering personalized technology-enabled care to their patients. The acquisition is intended to expand the former company's eye care-based digital solutions portfolio. The company is also focusing on expanding the business in Asia Pacific owing to larger patient pool in this region.

Browse full research report with TOC on "Ophthalmology PACS Market Size, Share & Trends Analysis Report By Type (Integrated, Standalone), By End Use (Hospitals, Specialty Clinics), By Delivery Mode (Cloud-based, On-Premise), And Segment Forecasts, 2018 - 2025"at:https://www.grandviewresearch.com/industry-analysis/ophthalmology-picture-archiving-communication-system-pacs-market

Further Key Findings From the Report Suggest:

  • Increasing cases of ophthalmic diseases, lack of skilled ophthalmologists, and growing usage of teleophthalmology solutions in developed countries are the factors driving the market
  • According to BrightFocus Foundation's survey, prevalence of Age-related Macular Degeneration (AMD) is anticipated to rise up to 22 million by 2040. This is also likely to boost market growth
  • Cloud-based PACS is anticipated to register lucrative growth during the forecast period owing to features, such as interoperability and mutual performance, privacy and security, reduced errors, and improved quality
  • North America held the major share of the market in 2017 due to increased ophthalmic disease burden and healthcare expenditure by public and private firms in this region
  • Asia-Pacific is anticipated to register the highest CAGR during forecast period due to rising prevalence of glaucoma coupled with high demand for an effective diagnostic solution
  • Carl Zeiss Meditec AG; Topcon Corp.; Merge Healthcare, Inc. are the major companies in the global ophthalmology PACS market
  • Most of these companies are focusing on technological advancements, M&A, and R&D as part of their business expansion strategies

Connect with our analyst for specific inquiries

Browse related reports by Grand View Research:

  • Veterinary Software Market - The global veterinary software market size was valued at USD 322.8 million in 2016 and is expected to grow with a CAGR of 8.9% during the forecast period.
  • ePharmacy Market - The global ePharmacy market size was valued at USD 33.03 billion in 2016 and is projected to grow at a CAGR of 14.8% during the forecast period.
  • e-Pharma Market - The global e-Pharma market size was valued at USD 33.03 billion in 2016 and is projected to grow at a CAGR of 14.8% during the forecast period.
  • mHealth App Market - The mHealth app market size was valued at USD 4.19 billion in 2016 and is projected to grow at a CAGR of 44.2% over the forecast period.

Grand View Research has segmented the global ophthalmology PACS market on the basis of type, delivery mode, end-use, and region:

  • Ophthalmology PACS Type Outlook (Revenue, USD Million, 2014 - 2025)
    • Standalone PACS
    • Integrated PACS
  • Ophthalmology PACS Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)
    • On-Premise System
    • Cloud-Based System
  • Ophthalmology PACS End-use Outlook (Revenue, USD Million, 2014 - 2025)
    • Hospital
    • Specialty Clinics
    • Others
  • Ophthalmology PACS Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
    • Latin America
      • Mexico
      • Brazil
    • Middle East & Africa
      • South Africa

Explore the BI enabled intuitive market research database,Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter


© 2019 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.